Comparison of the HOTV and Lea symbols visual acuity test in patients with amblyopia

Eye Institute, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Journal of Pediatric Ophthalmology & Strabismus (Impact Factor: 0.75). 05/2006; 43(3):157-60.
Source: PubMed


To determine whether the Lea symbols visual acuity test, compared with the HOTV visual acuity test, overestimates visual acuity in patients with amblyopia.
Fifty-nine patients with amblyopia or a history of amblyopia treatment had visual acuity measurements in both eyes with the HOTV and Lea symbols tests. Crowding bars, separated by a width of 1 optotype, and the original pilot-testing protocol in the Amblyopia Treatment Study were used to quantify visual acuity.
The patients' ages ranged from 4 to 35 years (mean age, 10.1 years). Visual acuity in the amblyopic eyes ranged from 20/20 to 20/250. The mean visual acuity difference (HOTV scores vs Lea symbols scores) was -0.056 logMAR units (P < .001), slightly more than half of a line. The negative value indicates that patients performed better on the HOTV test. In nonamblyopic eyes, the mean difference was -0.05 logMAR units (P < .001). Patients with strabismic amblyopia had a mean difference of -0.05 logMAR units (P = .08); those with anisometropic amblyopia had a mean difference of -0.07 logMAR units (P = .002). Patients 8 years and younger had a mean difference of -0.04 logMAR units (P = .05); those older than 8 years had a mean difference of -0.06 logMAR units (P = .002).
In both amblyopic and nonamblyopic eyes, visual acuity measurements were better on HOTV testing compared with Lea symbols testing. The differences persisted regardless of patient age and the cause and severity of amblyopia. Overestimation of visual acuity by the Lea symbols test was not found.

28 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Treatment for unilateral amblyopia has two principal components: refractive correction by spectacles and occlusion of the fellow eye. Until recently, knowledge of the dose-response for occlusion by patching was very sparse and, consequently, prescribed doses of treatment varied from 10 min per day, up to full time. Recent clinical trials concerning the effectiveness of occlusion by patching and atropine penalization have provided us with an evidence base on which to prescribe treatment appropriately. This article aims to summarize recent work on treatment for amblyopia and discuss the treatment options, providing the possible treatment plans available to the clinician.
    No preview · Article · Jul 2007 · Expert Review of Ophthalmology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Traditional treatment of amblyopia, although still in use and of great value, has recently been challenged by data from studies relative to efficacy of different modalities and regimens of therapy. LogMAR-based acuity charts should be used, whenever possible, for diagnosis and monitoring. Refractive errors of certain magnitude should be prescribed, and correction worn for at least 4 months before occlusion or penalization are used. Occlusion has a linear dose-response effect (1 logMAR line gain per 120 hours of patching), and outcomes of 2 hour/day dosage are similar to more extended therapy, at least in moderate amblyopia, but increasing dosage beyond hastens the response. Pharmacologic, optical, or combined penalization is useful as an alternative or maintaining therapy, and is presumably of particular efficacy in anisometropic amblyopia. At least in moderate amblyopia, atropine penalization is as effective as patching in terms of visual acuity improvement and stereoacuity outcome.
    Preview · Article · Jan 2008 · Clinical ophthalmology (Auckland, N.Z.)
  • [Show abstract] [Hide abstract]
    ABSTRACT: Amblyopia is defined as reduced and uncorrectable vision in a structurally normal eye. Early detection of amblyopia is very important. This can be accomplished through screening programs designed to identify amblyopia risk factors. Testing can be performed by trained teachers, technicians, school nurses and pediatricians as well as by eye care professionals. Once a child is identified as having an amblyopia risk factor it is crucial that the parents follow up with a pediatric ophthalmologist for a comprehensive examination. Amblyopia is the leading cause of monocular vision loss in the United States for adults under the age of 40. Amblyopia is amenable to therapy and is cost effective to treat. It is believed that earlier therapy for amblyopia provides better outcomes, but treatment has been shown effective even in some older children. In this paper, studies are cited regarding treatment of amblyopia.
    No preview · Article · Sep 2010 · American Orthoptic Journal
Show more